drugset / Trial / NCT06184958

Potential Role of Intravenous Lidocaine Versus Intravenous Ketamine for Pain Management in Fibromyalgia Patients

NCT06184958 ↗

Phase 4 Unknown 75 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the study is to assess the efficacy of intravenous lidocaine versus intravenous ketamine in treatment of fibromyalgia patients.

Timeline

Start
2023-09-02
Primary completion
2024-02
Completion
2024-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg Intravenous
Comparator Lidocaine Other / unclassified 5 mg/kg Intravenous

Indications

No indication recorded.